This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Fred Hutchinson Cancer Center, University of Washington. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 309 
1 out of 2,172 
Years Active: 2025
Title: Sylvia Lee: Innovator in Cancer Treatment
Introduction
Sylvia Lee is a prominent inventor based in Seattle, WA, known for her significant contributions to cancer research. With a focus on developing innovative therapies, she has made strides in the field of immunology and oncology.
Latest Patents
Sylvia Lee holds a patent for "BRAF-specific TCRs and uses thereof." This patent provides binding proteins, such as T-cell receptors (TCRs), that specifically bind to various tumor-associated antigens, including the human BRAFV600E epitope. The invention includes cells expressing these antigen-specific binding proteins, nucleic acids encoding them, and compositions for treating diseases or disorders where cells express BRAFV600E, particularly in cancer.
Career Highlights
Throughout her career, Sylvia has worked with esteemed institutions such as the Fred Hutchinson Cancer Center and the University of Washington. Her work has been pivotal in advancing the understanding and treatment of cancer through innovative approaches.
Collaborations
Sylvia has collaborated with notable colleagues, including Joshua Veatch and Stanley R. Riddell, contributing to a rich environment of research and development in cancer therapies.
Conclusion
Sylvia Lee's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. Her contributions continue to inspire advancements in therapeutic strategies for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile